NeuroCog Trials receives $1.2M NIMH grant

Monday, October 1, 2012 09:09 AM

NeuroCog Trials, a Durham, N.C.-based cognitive services provider for the clinical trials industry, has received a 2012 phase II grant from the Small Business Innovation Research (SBIR) program from the National Institute of Mental Health (NIMH), for the validation and commercialization of its Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

NeuroCog Trials had already successfully completed phase I of this project involving the development of the VRFCAT in collaboration with Virtual Heroes, a division of Applied Research Associates.

"Following our early success with the VRFCAT, we set out to secure additional funding to support its validation and commercialization. We aim for the VRFCAT to be used as a reliable tool in clinical trials to measure changes in functional capacity associated with the pro-cognitive effects of novel drugs for schizophrenia, bipolar disorder, Alzheimer's disease and other diseases,” said Richard Keefe, founder and CEO of NeuroCog Trials.

The VRFCAT is a novel virtual reality measure that assesses patients' ability to navigate a variety of daily challenges using realistic, simulated environments.

"The VRFCAT fits into our strategic growth plan involving the development of a cutting edge computerized assessment tool with a game-like feel to increase patient interest and adherence,” said Caren Gadigian, president of NeuroCog Trials. “The VRFCAT expands our assessment portfolio from traditional paper and pencil neurocognitive measures and our Computerized Brief Assessment of Cognition in Schizophrenia (C-BACS) developed for the iPad platform, to now include this virtual reality tool."

The SBIR grant evaluation process considers the degree of innovation, qualifications of the principal investigator and other key staff, the soundness and technical merit of the proposal research and the potential for commercial applications.  Special consideration is given to the originality of the proposal in solving technological challenges. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs